SEC Form 4 · accession 0001481485-26-000004
TELA Bio, Inc. · TELA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Heather C Getz
Officer — Chief Executive Officer · Director
Period of report
Aug 3, 2026
Accepted (ET)
Aug 5, 2026 · 4:09 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001561921
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 3, 2026 | A | 500,000 | $0.00 | A | 505,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.74 | Aug 3, 2026 | A | 1,365,000 | A | — | Aug 3, 2036 | Common Stock | 1,365,000 | 1,365,000 | D |
| Stock Option (Right to Buy)F2 | $0.90 | Aug 3, 2026 | A | 1,005,000 | A | — | Aug 3, 2036 | Common Stock | 1,005,000 | 1,005,000 | D |
Explanation of responses
- F1These restricted stock units will vest in four equal annual installments beginning on August 3, 2027, in each case subject to the Reporting Person's continued service through the applicable vesting date.
- F2The option vests 25% on August 3, 2027, with the remaining 75% vesting in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.